Wednesday, September 29, 2010

FDA Revises Rules on Reporting Safety Information During Clinical Trials

The FDA on Tuesday issued a final rule clarifying how and when safety information must be reported during clinical trials of investigational drugs and biologics. Read more.

No comments:

Post a Comment